Industry Funding Opportunities

October 5, 2021

J&J Innovation: Mechanism of Exosome Uptake from the GI Tract

Submission Deadline: October 15, 2021

Johnson & Johnson Innovation wishes to identify research focused on the mechanism of exosome uptake across the gastrointestinal (GI) epithelium,...

October 5, 2021

New Therapeutic Strategies Targeting Myeloid Malignancies

Submission Deadline: October 25, 2021

A global pharmaceutical company with cutting-edge capabilities in drug development and a history of successful academic collaborations wishes to...

October 5, 2021

Benitec Biopharm Opportunity: Monogenic Targets for RNA Interface-Based Therapy

Submission Deadline: November 1, 2021

Benitec Biopharma is an American biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference (RNAi)...

October 5, 2021

J&J: Therapeutic Agents for Kidney Repair

Submission Deadline: November 8, 2021

Johnson & Johnson Innovation is interested in developing therapeutics for kidney diseases, including Chronic Kidney Disease (CKD), Diabetic Kidney...

October 5, 2021

Seeking Genetically-Based Early Discovery Research in Nephrology

Submission Deadline: November 15, 2021

BioMarin Pharmaceutical Inc. is a world leader in developing and commercializing first- or best-in-class therapies for rare genetic diseases....

August 3, 2021

J&J Packaging Design QuickFire Challenge: Unit Dose Technologies

Submission Deadline: October 15, 2021

Johnson & Johnson Innovation, together with the packaging innovation team within Johnson & Johnson Consumer Inc., is launching the Packaging...

May 14, 2021

Partnership with BridgeBio on Genetic Diseases

The University of Pittsburgh has launched a new partnership with BridgeBio to accelerate the development of breakthrough therapies for genetic diseases and...